Deciphering the Causal Influence of BMI and Related Metabolic, Inflammatory, and Cardiovascular Factors on Brain Structure: A Mendelian Randomization Study

Why It Matters

Demonstrating a causal link between obesity and cortical thinning underscores the need for weight‑management strategies to protect brain health and mitigate future mental‑illness risk.

Key Takeaways

• Higher BMI causally reduces cortical thickness.
• Precentral and fusiform gyri most affected.
• Visceral fat and CRP show similar thinning patterns.
• Blood pressure shows minimal cortical impact.
• Findings suggest obesity-driven neurodegeneration risk.

Pulse Analysis

Obesity’s surge across global populations has sparked intense research into its systemic consequences, yet the directionality of its impact on the brain remains debated. Traditional cross‑sectional imaging studies reveal correlations between higher body mass index and thinner cortical regions, but they cannot disentangle whether excess weight drives neural loss or vice‑versa. Mendelian randomization (MR) leverages genetic variants as instrumental variables, offering a quasi‑experimental framework that approximates randomized trials. By applying both univariate and multivariate MR, the authors isolate BMI’s direct effect on cortical architecture, sidestepping confounders that plague observational designs.

The analysis uncovers a robust causal pathway: each genetically predicted unit increase in BMI translates into measurable cortical thinning, with the precentral and fusiform gyri bearing the greatest burden. Parallel nominal associations emerge for visceral adipose tissue and circulating C‑reactive protein, hinting that central fat accumulation and low‑grade inflammation may mediate the structural decline. In contrast, systolic and diastolic blood pressure, alongside standard metabolic biomarkers, show negligible influence on cortical thickness, suggesting that not all obesity‑related physiologic changes equally affect the brain. These nuanced findings refine the mechanistic map linking adiposity, inflammation, and neuroanatomy.

Clinically, establishing BMI as a driver of cortical atrophy elevates obesity from a peripheral metabolic concern to a central neuropsychiatric threat. Reduced cortical thickness, particularly in motor and visual processing hubs, aligns with heightened vulnerability to depression, dementia, and cognitive decline. Public‑health policies should therefore integrate neuroprotective objectives into weight‑loss programs, emphasizing anti‑inflammatory diets and visceral fat reduction. Future research must probe whether reversing BMI‑induced thinning—through lifestyle interventions or pharmacotherapy—can restore neural integrity and lower psychiatric incidence, thereby translating genetic insights into actionable prevention strategies.